Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function
- PMID: 22869154
- PMCID: PMC3767573
- DOI: 10.1007/s11892-012-0305-4
Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function
Abstract
Islet cell transplantation has therapeutic potential to cure type 1 diabetes (T1D), which is characterized by autoimmune-mediated destruction of insulin-producing β cells. However, current success rates are limited by long-term decline in islet graft function resulting partially from poor revascularization and immune destruction. Mesenchymal stem cells (MSCs) have the potential to enhance islet transplantation and prevent disease progression by a multifaceted approach. MSCs have been shown to be effective at inhibiting inflammatory-mediated immune responses and at promoting tissue regeneration. The immunomodulatory and tissue repairing properties of MSCs may benefit β cell regeneration in the context of T1D. This review will elucidate how MSCs can minimize β cell damage by providing survival signals and simultaneously modulate the immune response by inhibiting activation, and proliferation of several immune cell types. In addition, MSCs can enhance islet graft revascularization, maintaining long-term β cell viability and function.
Figures
Similar articles
-
Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.Cytotherapy. 2018 Sep;20(9):1124-1142. doi: 10.1016/j.jcyt.2018.06.001. Epub 2018 Jul 29. Cytotherapy. 2018. PMID: 30068495
-
Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.Immunol Lett. 2017 Aug;188:21-31. doi: 10.1016/j.imlet.2017.05.006. Epub 2017 May 12. Immunol Lett. 2017. PMID: 28506774
-
Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.Autoimmunity. 2006 Jun;39(4):315-21. doi: 10.1080/08916930600648269. Autoimmunity. 2006. PMID: 16891220
-
Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.Diabetes Metab. 2009 Apr;35(2):85-93. doi: 10.1016/j.diabet.2008.10.003. Epub 2009 Feb 20. Diabetes Metab. 2009. PMID: 19230736 Review.
-
Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function.Front Endocrinol (Lausanne). 2022 Feb 9;13:822191. doi: 10.3389/fendo.2022.822191. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35222280 Free PMC article. Review.
Cited by
-
The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions.J Immunol Res. 2018 Sep 23;2018:2424586. doi: 10.1155/2018/2424586. eCollection 2018. J Immunol Res. 2018. PMID: 30345316 Free PMC article. Review.
-
Advances in the cellular immunological pathogenesis of type 1 diabetes.J Cell Mol Med. 2014 May;18(5):749-58. doi: 10.1111/jcmm.12270. Epub 2014 Mar 14. J Cell Mol Med. 2014. PMID: 24629100 Free PMC article. Review.
-
Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms.Sci Rep. 2014 Apr 2;4:4565. doi: 10.1038/srep04565. Sci Rep. 2014. PMID: 24691433 Free PMC article.
-
Noninvasive Monitoring of Allogeneic Stem Cell Delivery with Dual-Modality Imaging-Visible Microcapsules in a Rabbit Model of Peripheral Arterial Disease.Stem Cells Int. 2019 Mar 14;2019:9732319. doi: 10.1155/2019/9732319. eCollection 2019. Stem Cells Int. 2019. PMID: 31001343 Free PMC article.
-
Minireview: Directed Differentiation and Encapsulation of Islet β-Cells-Recent Advances and Future Considerations.Mol Endocrinol. 2015 Oct;29(10):1388-99. doi: 10.1210/me.2015-1085. Epub 2015 Sep 4. Mol Endocrinol. 2015. PMID: 26340406 Free PMC article. Review.
References
-
- Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147. - PubMed
-
- Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature Reviews Immunology. 2008;8(9):726–736. - PubMed
-
- Rafei M, et al. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner. The Journal of Immunology. 2009;182(10):5994–6002. - PubMed
-
- Papadopoulou A, et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2012 - PubMed
-
- Choi EW, et al. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue–derived mesenchymal stem cell transplantation. Arthritis & Rheumatism. 2012;64(1):243–253. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical